Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.

Paul S Calara; Jenny M Norlin; Rikard Althin; Katarina Steen Carlsson; Marcus Schmitt-Egenolf

doi:10.1007/s40259-016-0163-8

Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.

Paul S Calara, Jenny M Norlin, Rikard Althin, Katarina Steen Carlsson, Marcus Schmitt-Egenolf

Research output: Contribution to journal › Article › peer-review

Abstract

Previous research indicates an uneven uptake of biologics in patients with moderate-to-severe psoriasis in Sweden. Therefore, it is essential to scrutinise variations in treatment patterns.

Original language	English
Journal	BioDrugs
Early online date	2016 Feb 16
DOIs	https://doi.org/10.1007/s40259-016-0163-8
Publication status	Published - 2016

Subject classification (UKÄ)

Dermatology and Venereal Diseases

Access to Document

10.1007/s40259-016-0163-8

http://www.ncbi.nlm.nih.gov/pubmed/26883786?dopt=Abstract

Cite this

@article{821b3f88f5d4481caddaf23967279b6e,

title = "Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.",

abstract = "Previous research indicates an uneven uptake of biologics in patients with moderate-to-severe psoriasis in Sweden. Therefore, it is essential to scrutinise variations in treatment patterns.",

author = "Calara, \{Paul S\} and Norlin, \{Jenny M\} and Rikard Althin and \{Steen Carlsson\}, Katarina and Marcus Schmitt-Egenolf",

year = "2016",

doi = "10.1007/s40259-016-0163-8",

language = "English",

journal = "BioDrugs",

issn = "1173-8804",

publisher = "Adis",

}

TY - JOUR

T1 - Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.

AU - Calara, Paul S

AU - Norlin, Jenny M

AU - Althin, Rikard

AU - Steen Carlsson, Katarina

AU - Schmitt-Egenolf, Marcus

PY - 2016

Y1 - 2016

N2 - Previous research indicates an uneven uptake of biologics in patients with moderate-to-severe psoriasis in Sweden. Therefore, it is essential to scrutinise variations in treatment patterns.

AB - Previous research indicates an uneven uptake of biologics in patients with moderate-to-severe psoriasis in Sweden. Therefore, it is essential to scrutinise variations in treatment patterns.

UR - https://www.scopus.com/pages/publications/84958745150

U2 - 10.1007/s40259-016-0163-8

DO - 10.1007/s40259-016-0163-8

M3 - Article

C2 - 26883786

SN - 1173-8804

JO - BioDrugs

JF - BioDrugs

ER -

Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.

Abstract

Subject classification (UKÄ)

Access to Document

Other files and links

Fingerprint

Cite this